Roche

VMLY&R Health welcomes Jo Crouch and Khalid Latif to senior executive team in London

Over the course of two decades, Crouch has taken on various roles, starting out in sales and marketing with Roche Diagnostics.

Roche announces two-year data confirming Vabysmo improves neovascular age-related macular degeneration

Roche has announced two-year data reinforcing the long-term efficacy, safety and durability of Vabysmo (faricimab) for the treatment of neovascular age-related macular degeneration (nAMD), a leading cause of

Roche’s Lunsumio granted Priority Review by FDA for people with relapsed or refractory follicular lymphoma

Roche’s Lunsumio (mosunetuzumab) has been given a Priority Review by the US Food and Drug Administration (FDA) following its acceptance of the company’s Biologics License Application. ... Clinical trial results have demonstrated durable responses

LADBible Haemophilia

by Hanover Communications for Roche. Haemophilia is a rare bleeding disorder surrounded by many misconceptions. ... The project from Hanover and Roche had impressive statistics backed up by a creative brief.

AD Taxi: Driving Forward Our Fight against Alzheimer's Disease

Being Bella: A Patient-Centric Approach to Clinical Trial Investigator Engagement - by Langland for Roche. ... AD Taxi: Driving Forward Our Fight against Alzheimer's Disease - by Health Interactions (a Nucleus Global agency) and 90TEN for Roche.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]